AAAAAA
Results:
1-10
|
Results: 10
Authors:
Vansteenkiste, JF
Vandebroek, JE
Nackaerts, KL
Weynants, P
Valcke, YJ
Verresen, DA
Devogelaere, RC
Marien, SA
Humblet, YP
Dams, NL
Citation: Jf. Vansteenkiste et al., Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine, ANN ONCOL, 12(9), 2001, pp. 1221-1230
Authors:
Vansteenkiste, J
Gatzemeier, U
Manegold, C
Hanauske, A
Weynants, P
Bosquee, L
Blatter, J
Mansouri, K
von Pawel, J
Citation: J. Vansteenkiste et al., Gemcitabine plus etoposide in chemonaive extensive disease small-cell lungcancer: A multi-centre phase II study, ANN ONCOL, 12(6), 2001, pp. 835-840
Authors:
Karanikas, V
Colau, D
Baurain, JF
Chiari, R
Thonnard, J
Gutierrez-Roelens, I
Goffinet, C
Van Schaftingen, E
Weynants, P
Boon, T
Coulie, PG
Citation: V. Karanikas et al., High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival, CANCER RES, 61(9), 2001, pp. 3718-3724
Authors:
Weynants, P
Citation: P. Weynants, Immunity and lung cancer: perspectives for an antitumor vaccine, REV MAL RES, 17(1), 2000, pp. 371-380
Authors:
Weynants, P
Thonnard, J
Marchand, M
Delos, M
Boon, T
Coulie, PG
Citation: P. Weynants et al., Derivation of tumor-specific cytolytic T-cell clones from two lung cancer patients with long survival, AM J R CRIT, 159(1), 1999, pp. 55-62
Authors:
van de Velde, H
Bosquee, L
Weynants, P
Canon, JL
Rosier, JF
Humblet, Y
Citation: H. Van De Velde et al., Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: Prolonged intrathoracic tumor control and high central nervous system relapse rate, ANN ONCOL, 10(9), 1999, pp. 1051-1057
Authors:
Weynants, P
Baurain, JF
Thonnard, J
Marchand, M
Boon, T
Coulie, P
Citation: P. Weynants et al., Progress in developing a specific vaccine against bronchial cancer, REV MAL RES, 16(1), 1999, pp. S214-S215
Authors:
Dunbar, PR
Chen, JL
Chao, D
Rust, N
Teisserenc, H
Ogg, GS
Romero, P
Weynants, P
Cerundolo, V
Citation: Pr. Dunbar et al., Cutting edge: Rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma, J IMMUNOL, 162(12), 1999, pp. 6959-6962
Authors:
Van den Eynde, B
Gaugler, B
Probst-Kepper, M
Michaux, L
Devuyst, O
Lorge, F
Weynants, P
Boon, T
Citation: B. Van Den Eynde et al., A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription, J EXP MED, 190(12), 1999, pp. 1793-1799
Authors:
Marchand, M
van Baren, N
Weynants, P
Brichard, V
Dreno, B
Tessier, MH
Rankin, E
Parmiani, G
Arienti, F
Humblet, Y
Bourlond, A
Vanwijck, R
Lienard, D
Beauduin, M
Dietrich, PY
Russo, V
Kerger, J
Masucci, G
Jager, E
De Greve, J
Atzpodien, J
Brasseur, F
Coulie, PG
Van der Bruggen, P
Boon, T
Citation: M. Marchand et al., Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1, INT J CANC, 80(2), 1999, pp. 219-230
Risultati:
1-10
|